Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07837245). This is a study registration, not published results. Lead sponsor: Institute of Oncology Ljubljana. Recruitment status: ENROLLING_BY_INVITATION. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 2150 participants (ESTIMATED). Conditions: Breast Cancer Screening. Interventions: DIAGNOSTIC_TEST: Screening Mammography. Primary outcome measures: Screening Participation Rate , From invitation to the scheduled screening mammography appointment, approximately 3-4 weeks; Referral Rate for Additional Assessment , At screening mammography, approximately 3-4 weeks after invitation. Brief summary: This prospective interventional clinical study evaluates the feasibility of expanding the Slovenian national breast cancer screening programme DORA to women aged 45-49 years and 70-74 years. Women from selected municipalities will be invited to screening mammography. The study will assess participation rates, the proportion of women referred for additional diagnostic assessment, and other indicators relevant to planning the future expansion of the DORA programme.